CD4 and neoplasm: Moreover, the antitumor effect of IFNα–IMQ combination therapy was abolished in treated c-JunΔ/ΔCD11c-Cre mice, with a reduction in tumor-infiltrating CD4+ T cells (Extended Data Fig. 7g,h).